Company / Free Cash Flow per Share
Compass Therapeutics, Inc. Free Cash Flow per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.33
FY2024
5-year range
-$0.87 / -$0.27
FY2020-FY2024
Trend
-2.3%
vs FY2023
Sector context
#76 of 190
Health Care
What the data says
At $-0.33, Compass Therapeutics, Inc.'s free cash flow per share ranks #76 of 190 in the Health Care sector. Declined from $-0.27 to $-0.33 over the past 2 years.
Based on SEC 10-K filings.
-0.33 in FY2024.
Declined from $-0.27 to $-0.33 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 190 in Health CareTop 40% of 190This company -$0.33 Sector average $3.32
▼
-109.8% below sector average
Key checks
Key Insights
- In FY2024, free cash flow per share decreased 2.3% year-over-year.
- Ranks #76 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2022.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.33 | -2.3% |
| FY2023 | -$0.32 | -17.1% |
| FY2022 | -$0.27 | +19.5% |
| FY2021 | -$0.34 | +61.4% |
| FY2020 | -$0.87 | +81.8% |
| FY2019 | -$4.81 | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026